Skip to main content
. 2007 Apr;148(1):85–89. doi: 10.1111/j.1365-2249.2006.03293.x

Fig. 1.

Fig. 1

Soluble Fas ligand (sFasL) in controls, primary biliary cirrhosis (PBC) and chronic hepatitis C (CH-C). PBC and CH-C present high levels of sFasL, which is undetectable in controls. Soluble FasL is higher in PBC than in CH-C.